Top Stories on Abilify |
Bristol-Myers Squibb to buy ZymoGenetics for $885 million, or $9 ... - St. John's TelegramIts other products include the psychiatric disorder treatment Abilify, Reyataz and Sustiva for HIV, Sprycel for cancer, and Onglyza for diabetes.Bristol-Myers agrees to buy ZymoGenetics - Metronews.caIts other products include the psychiatric disorder treatment Abilify, Reyataz and Sustiva for HIV, Sprycel for cancer, and Onglyza for diabetes.NICE wants more data on BMS schizophrenia drug - Reuters UKLONDON (Reuters) - Britain's healthcare cost watchdog said it was unable to recommend use of Bristol-Myers Squibb's schizophrenia drug Abilify in children aged 15 to 17 and has ...BMY to Acquire ZymoGenetics - Zacks.comThe company, which has lost patent protection on products worth about $4 billion over the past few years, has already taken measures like the extension of the Abilify agreement ...BMY to take ZGEN Under its Wings - Yahoo FinanceThe company, which has lost patent protection on products worth about $4 billion over the past few years, has already taken measures like the extension of the Abilify agreement ...Bristol-Myers Squibb to acquire Seattle ... - NJ.comIts other products include the psychiatric disorder treatment Abilify, Reyataz and Sustiva for HIV, Sprycel for cancer, and Onglyza for diabetes. |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
